Antibiotics & Metabolites

Antibiotic LL Z1640-2 is an inhibitor against the TAK1 activity.

Antibiotic MA 144M2 is an anthracycline glycoside that inhibits the growth of gram-positive bacteria, e.g. Staphyococcus aureaus, Bacillus subtilis and Sarcina lutea, and inhibits the growth of animal tumors such as leukemia L 1210, P 388 and sarcoma 180. It's produced by fermentation of MA 144-producing strains of streptomyces and by the chemical or enzymatic conversion of aclacinomycin A or cinerubin A.

Antibiotic MA 144M1 is an anthracycline glycoside that inhibits the growth of gram-positive bacteria, e.g. Staphyococcus aureaus, Bacillus subtilis and Sarcina lutea, and inhibits the growth of animal tumors such as leukemia L 1210, P 388 and sarcoma 180. It's produced by fermentation of MA 144-producing strains of streptomyces and by the chemical or enzymatic conversion of aclacinomycin A or cinerubin A.

Inhibits transcription in cell biology by binding DNA at the transcription initiation complex and preventing elongation of RNA chain by RNA polymerase

Inhibits transcription in cell biology by binding DNA at the transcription initiation complex and preventing elongation of RNA chain by RNA polymerase

Aminoglycoside antibiotic

Aminoglycoside antibiotic. Highest solubility, absorption and effectiveness.

Acts against gram-negative and gram-positive bacteria.

Aminoglycoside antibiotic